Abstract:OBJECTIVE:To explore the circadian blood pressure (BP) profile and its influencing factors in essential hypertensive patients after treatment. METHODS:Cross-sectional surveillance was carried out in essential hypertensive subjects after treatment whose clinic blood pressure had been under control as 140/90 mm Hg (1 mm Hg = 0.133 kPa) for at least one month. All patients underwent a twenty-four-hour ambulatory blood pressure monitoring device (spacelabs 90207). The nocturnal fall of blood pressure (BP) was calculated from (daytime mean BP-night-time mean BP)/daytime BP, while 'daytime' values were recorded between 6 h and 22 h and 'night-time' values between 22 h and 6 h. Non-dippers were defined as those whose nocturnal decrease in mean systolic BP and/or mean diastolic BP was < 10% of the daytime BP. Binary logistic regression analysis was used to evaluate the correlation between circadian blood pressure profile and factors as gender, age, height, body mass index (BMI), family history of premature cardiovascular disease, women under age 65 or men under age 55, smoking habits, grade of hypertension, and strategy of antihypertensive drugs. RESULTS:208 treated essential hypertensive patients were enrolled in the study. 79 individuals were dippers and 129 were non-dippers. Data from logistic regression analysis showed that four factors as age, premature family history of cardiovascular disease, overweight or obesity, and strategy of antihypertensive drugs were significantly influencing the circadian blood pressure profile in treated hypertensive patients. The incidence of non-dippers in patients of 70 years of age or older and those between 60 and 69 were 3.3 and 2.3 times of those with less than 60 (P = 0.009 and 0.031, respectively). The prevalence of non-dippers in patients with a premature family history of cardiovascular disease was 3.7 times greater than those in subjects without a premature history of cardiovascular disease (P = 0.029). Similarly, the incidence of non-dippers in patients of overweight (24 = BMI < 28) and obesity (BMI >/= 28) were 3.0 and 4.8 times of those in subjects of normal weight (P = 0.003 and 0.009, respectively). Compared with patients treated with long-acting calcium channel blockers (CCBs), patients treated with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) alone had less prevalence of nondippers (OR = 0.139, P = 0.010). Patients treated with joint antihypertensive scheme including ACE inhibitors or ARBs(but not including diuretics) had the tendency of lower incidence of abnormal circadian blood pressure rhythm (OR = 0.453, P = 0.118). Patients treated with joint antihypertensive scheme including diuretics (not including ACE inhibitors or ARBs) and with joint antihypertensive strategy including diuretics and ACE inhibitors or ARBs had lower incidence of nondippers (OR = 0.378 and 0.273, respectively; P = 0.030 and 0.011, respectively). CONCLUSIONS:Approximately 2/3 treated essential hypertensive patients had a non-dipper blood pressure profile. Age, premature family history of cardiovascular disease, overweight/obesity, and antihypertensive drugs strategy were correlated with circadian blood pressure profile. Compared with long-acting CCBs, diuretics, ACE inhibitors or ARBs might be helpful in keeping the circadian blood pressure rhythm at normal range.

Relationship Between Matrix Metalloproteinases-9 and Circadian Rhythm of Blood Pressure in Patients with Essential Hypertension

The Changes of Serum Matrix Metalloproteinase-9 and Tissue Inhibitor Metalloproteinase-1 in Essential Hypertension

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

Profile on Circadian Blood Pressure and the Influencing Factors in Essential Hypertensive Patients after Treatment

Study of the relationship between blood pressure variability and arrhythmia of patients with essential hypertension

Analysis of the Reasons of Abnormal Circadian Blood Pressure in Patients with Hypertension

Clinical significance of serum interleukin-18 (IL-18) and matrix metalloproteinase-(MMP-9) on acute coronary syndrome

Relationship Between Matrix Metalloproteinase-9 and Tissue Metalloproteinase Inhibitor-1 and Carotid Atheromatous Plaque Stability

Relations of serum MMP-1 and MMP-9 levels with left ventricular hypertrophy in the elderly with hypertension

Relation of Metalloproteinase 9 and Its Inhibitor with Carotid Artery Atherosclerosis in Aged Patients with Hypertension

Alteration characteristics and influencing factors of circadian rhythm of blood pressure in the elderly with well-controlled hypertension

Relationship between serum iron and essential hypertension

Relationship between Benign Prostatic Hyperplasia and Blood Pressure Circadian Rhythm

Study of the Relation Between Blood Pressure Parameters and Urine Microprotein in Essential Hypertension Subjects

Relationship between circadian rhythm of blood pressure and target organ damage in essential hypertensive patients with type 2 diabetes mellitus

Heart rate deceleration and acceleration capacities associated with circadian rhythm of blood pressure in essential hypertension

Changes and Implication of Peripheral Blood Levels of Matrix Metalloproteases-9 and C-reactive Protein in Patients with Coronary Artery Disease

O59 INFLUENCE OF CIRCADIAN BLOOD PRESSURE PATTERN ON RIGHT VENTRICULAR STRUCTURE AND FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSIION

Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients

Changes of Blood Pressure Rhythm and Clock Protein Expression Levels in Spontaneously Hypertensive Rats After Ischemia-Reperfusion

PS-BPC12-8: ASSOCIATION OF URIC ACID WITH BLOOD PRESSURE LEVEL IN ESSENTIAL HYPERTENSION: DIFFERENCES ACCORDING TO DIPPING PATTERN OF NOCTURNAL BLOOD PRESSURE